drugset / Trial / NCT02813434

Cerebral Amyloid Imaging Using Florbetapir (AV-45)

NCT02813434

Phase 3 Completed 92 enrolled Centre Hospitalier Universitaire, Amiens
NaSingle-groupOpen-labelDiagnostic

Summary

This study is aimed at examining the interest of amyloid radiotracer Florbetapir (18F-AV-45) for the etiological diagnosis of poststroke cognitive impairment and dementia

Timeline

Start
2014-09-24
Primary completion
2025-01-07
Completion
2025-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject florbetapir Diagnostic / imaging agent

Indications